A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.

Prasad Eye Institute (LVPEI) organized the seventh edition of 'WHITATHON' a walk on May 18 at Patia Chowk, Bhubaneswar to ...

Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses.

Mankind Pharma on Wednesday reported a 10% year-on-year (YoY) decrease in net profit to Rs 429 crore in Q4 FY24, attributed to one-time costs related to the integration of BSV. Revenue from ...

(MENAFN- IANS) Mumbai, May 21 (IANS) Mankind Pharma on Wednesday reported a 10.7 per cent year-on-year (YoY) decline in net profit to Rs 420.8 crore for the quarter ended March 2025 (Q4 FY25 ...

Mankind Pharma Limited announced its results for the quarter ended March 2025 and posted a mixed set of numbers. Though the business reported a robust topline, it was offset by a slip in profit ...

Several stocks experienced declines in today's trading session, with Colgate, Mankind Pharma, and BSE Limited leading the list of losers within the NIFTY MIDCAP 150. The movement highlights ...

(Reuters) -Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses. The ...

These debentures will be issued in three to four distinct series with maturities of up to 48 months Mankind Pharma fund raising committee finalised a comprehensive plan to issue non-convertible ...